EXAS News and Press, Exact Sciences Corporation

2026-03-24 11:20:00 ET The following segment was excerpted from Columbia Cornerstone Growth Fund Q4 2025 Commentary. ... Read the full article on Seeking Alpha For further details see: Columbia Cornerstone Growth Fund...

2026-03-19 09:50:00 ET Abbott Laboratories (NYSE: ABT) , a medical device specialist, recently fell off a cliff after a disappointing quarterly update that missed consensus top-line estimates. The healthcare giant is roughly 22% down from its 52-week high of $139.06 as of writing....

The Oncodetect ® test expands the role of tumor-informed MRD in triple-negative breast cancer The Cancerguard ® test demonstrates improved early-stage multi-cancer detection performance Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer scr...

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced it has earned the 2026 Gallup Exceptional Workplace Award (GEWA), marking the third consecutive year the company has received this prestigious recognition. The award honors organizati...

Amalgam Rx, Inc., Privia Health, and Exact Sciences Corp. highlight how coordinated, EHR-enabled patient outreach supported measurable screening impact at scale. Amalgam Rx, Inc ., a leader in data-driven, AI-powered healthcare engagement and clinical decision support, today annou...

2026-02-25 09:40:00 ET Tilray Brands (NASDAQ: TLRY) , like many other cannabis stocks, has taken investors on a wild roller-coaster ride the past few years, though for the most part, that ride has been downward. The stock soared by more than 10 times in the months after its 2018...

2026-02-23 11:10:57 ET More on Abbott Laboratories, Exact Sciences Abbott: Long-Term Investment Opportunity For Dividend Growth Investors Abbott Laboratories: Double-Digit Earnings Growth Makes It A Buy Abbott Laboratories: The Market's Overreaction Is The Long-Term ...

2026-02-20 16:17:26 ET More on Exact Sciences Exact Sciences: Abbott Acquisition A Positive Sign For Oncology Diagnostics Exact Sciences ticks higher amid reports HSR for Abbott deal expired CyberArk/Palo Alto Networks, Dayforce/Thoma Bravo among good bets for deal c...

Exact Sciences Corporation (NASDAQ: EXAS) (“Exact Sciences”), a leading provider of cancer screening and diagnostic tests, today announced that its stockholders voted to approve the proposed acquisition of Exact Sciences by Abbott (NYSE: ABT) at the special meeting of stockholders h...

2026-02-18 10:48:02 ET More on Alphabet, Meta, etc. The Next Sector That Could Be Cannibalized By AI This Is When The Bull Market Is In Trouble S&P 500: The Path To 5,000 Is Getting Clearer Google takes wraps off budget Pixel 10a ahead of near imminent iP...